Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

General Description

Arvinas

Youtube Subscribe

...

Ticker: ARVN

Sector: Pharmaceuticals

Arvinas, Inc. engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company engineers proteolysis targeting chimeras (PROTAC) targeted protein degraders that.
...
...
Extended Summary

Arvinas

Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company engineers proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. Its product pipeline includes Bavdegalutamide and ARV-766, investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer, which are in Phase 1/2 clinical trials; and ARV-471, an orally bioavailable estrogen receptor degrading PROTAC targeted protein degrader for the treatment of patients with locally advanced or metastatic estrogen receptor+/human epidermal growth factor receptor 2-breast cancer, which is Phase 3 clinical trial. The company has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG. Arvinas, Inc. was founded in 2013 and is based in New Haven, Connecticut.

Related Results

...
February 29, 2024 22:52 (London Time)

Arvinas

Arvinas shareholders are still up 143% over 5 years despite pulling back 10% in the past week. Shareholders have received a total shareholder return…
Sector: Pharmaceuticals
Ticker: ARVN
Sentiment: 0.9559
MarketCap: 3,123,874,381.0
High: 48.19 Low: 45.89

Open: 47.46 Close: 45.98 Change: -1.48

Read more →
...
January 02, 2024 19:47 (London Time)

Arvinas

Arvinas Biotechnology New Haven, Connecticut, is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering f…
Sector: Pharmaceuticals
Ticker: ARVN
Sentiment: 0.765
MarketCap: 2,264,849,744.0
High: 42.83 Low: 39.26

Open: 40.76 Close: 41.25 Change: 0.49

Read more →
...
September 07, 2023 18:51 (London Time)

Arvinas

Swiss National Bank cut its stake in shares of Arvinas, Inc. Swiss National bank cut its stakes in shares. Swiss National National Bank owned approx…
Sector: Pharmaceuticals
Ticker: ARVN
Sentiment: 0.7184
MarketCap: 1,423,771,312.0
High: 26.47 Low: 25.93

Open: 26.47 Close: 26.45 Change: -0.02

Read more →
...
February 04, 2024 2:13 (London Time)

Arvinas

Goldman Sachs initiated coverage on Arvinas with a buy rating and price target of $70. Goldman Sachs: Breast cancer drug vepdegestrant (ARV-471) pre…
Sector: Pharmaceuticals
Ticker: ARVN
Sentiment: 0.9131
MarketCap: 2,527,321,398.0
High: 46.63 Low: 42.62

Open: 45.14 Close: 45.97 Change: 0.83

Read more →
...
November 21, 2023 4:47 (London Time)

Arvinas

Pfizer to pay at least $1 billion to develop, commercialize Arvins investigational breast-cancer therapy. Wall Street analysts predict a 165.07% Ups…
Sector: Pharmaceuticals
Ticker: ARVN
Sentiment: 0.7184
MarketCap: 1,151,133,543.0
High: 22.38 Low: 20.51

Open: 22.24 Close: 21.77 Change: -0.47

Read more →
...
April 19, 2023 13:40 (London Time)

Arvinas

Arvinas is a clinical-stage biotechnology company leading the way in targeted protein degradation therapeutics. Cantor Fitzgerald reaffirmed an “ove…
Sector: Pharmaceuticals
Ticker: ARVN
Sentiment: 0.8476
MarketCap: 1,438,863,232
High: 27.01 Low: 26.82

Open: 28.34 Close: 27.01 Change: -1.33

Read more →
Search
Happening Now
Categories